Wu Yu-Chieh, Bian Xue-Lin, Heaton Phillip R, Deyrieux Adeline F, Wilson Van G
Department of Microbial and Molecular Pathogenesis, College of Medicine, Texas A&M Health Science Center, Reynolds Medical Building, College Station, TX 77843-1114, USA.
Virology. 2009 Apr 25;387(1):176-83. doi: 10.1016/j.virol.2009.02.002. Epub 2009 Feb 28.
The stability of papillomavirus E2 proteins is regulated by proteasomal degradation, and regulation of degradation could contribute to the higher expression levels of E2 proteins observed in suprabasal layers of differentiated skin. We have recently shown that the E2 proteins are modified by sumoylation [Wu Y-C, Roark AA, Bian X-L, Wilson, VG (2008) Virol 378:329-338], and that sumoylation levels are up-regulated during keratinocyte differentiation [Deyrieux AF, Rosas-Acosta G, Ozbun MA, Wilson VG (2007) J Cell Sci 120:125-136]. These observations, coupled with the known ability of sumoylation to prevent proteasomal degradation of certain proteins, suggested that this modification might contribute to stabilizing E2 proteins in suprabasal keratinocytes. Conditions that increased overall sumoylation were found to increase the intracellular amounts of the HPV11, 16, and 18 E2 proteins. No effect of sumoylation was seen on E2 transcripts, and the increased levels of E2 proteins resulted from a greatly increased half-life for the E2 proteins. In vitro studies confirmed that sumoylation could block the proteasomal degradation of the 16E2 protein. Interestingly, this stabilization effect was indirect as it did not require sumoylation of 16E2 itself and must be acting through sumoylation of a cellular target(s). This sumoylation-dependent, indirect stabilization of E2 proteins is a novel process that may couple E2 levels to changes in the cellular environment. Specifically, our results suggest that the levels of papillomavirus E2 protein could be up-regulated in differentiating keratinocytes in response to the increased overall sumoylation that accompanies differentiation.
乳头瘤病毒E2蛋白的稳定性受蛋白酶体降解调控,而降解调控可能有助于在分化皮肤的基底层以上各层中观察到的E2蛋白更高表达水平。我们最近发现E2蛋白通过SUMO化修饰[Wu Y-C, Roark AA, Bian X-L, Wilson, VG (2008) Virol 378:329-338],并且SUMO化水平在角质形成细胞分化过程中上调[Deyrieux AF, Rosas-Acosta G, Ozbun MA, Wilson VG (2007) J Cell Sci 120:125-136]。这些观察结果,再加上已知SUMO化能够防止某些蛋白质的蛋白酶体降解,表明这种修饰可能有助于在基底层以上的角质形成细胞中稳定E2蛋白。发现增加总体SUMO化的条件会增加HPV11、16和18 E2蛋白的细胞内含量。未观察到SUMO化对E2转录本有影响,E2蛋白水平的增加是由于E2蛋白的半衰期大大延长。体外研究证实SUMO化可以阻断16E2蛋白的蛋白酶体降解。有趣的是,这种稳定作用是间接的,因为它不需要16E2自身的SUMO化,并且一定是通过细胞靶标的SUMO化起作用。E2蛋白这种依赖SUMO化的间接稳定作用是一个新过程,可能将E2水平与细胞环境的变化联系起来。具体而言,我们的结果表明,乳头瘤病毒E2蛋白的水平可能在分化的角质形成细胞中上调,以响应分化过程中伴随的总体SUMO化增加。